T. Rowe Price Investment Management, Inc. Abcam PLC Transaction History

T. Rowe Price Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$12.62 - $24.47 $140,359 - $272,155	-11,122 Reduced 0.17%	6,544,880 $160 Million
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $6.04 Million - $7.96 Million	465,616 Added 7.65%	6,556,002 $88.2 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $26.2 Million - $32 Million	1,882,321 Added 44.73%	6,090,386 $94.8 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $56.2 Million - $70.5 Million	4,208,065 New	4,208,065 $63.1 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.